We provide you with 20 years of free, institutional-grade data for HOOK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HOOK. Explore the full financial landscape of HOOK stock.
| Reported Date | CIK | Ticker | Type |
|---|
HOOKIPA Pharma Inc(NASDAQ:HOOK) 
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II cli...
Website: http://www.hookipapharma.com
Founded: 2011
Full Time Employees: 85
CEO: Jörn Aldag
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about HOOK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.